Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment

被引:14
|
作者
Bellver, Jose [1 ]
Albert, Carmen [1 ]
Labarta, Elena [1 ]
Pellicer, Antonio [1 ]
机构
[1] Univ Valencia, Inst Valenciano Infertilidad, E-46015 Valencia, Spain
关键词
GnRH antagonist; oral contraceptive pill; early pregnancy loss; ongoing pregnancy;
D O I
10.1016/j.fertnstert.2006.08.098
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate and compare the risk of early pregnancy loss in patients stimulated with GnRH antagonist protocols according to oral contraceptive pill (OCP) pretreatment. Design: Retrospective case-control study. Setting: Instituto Valenciano de Infertilidad. University of Valencia. Spain. Patient(s): One thousand five hundred thirty-nine patients, aged <36, stimulated with GnRH antagonists for IVF between January 1, 2000 and November 1, 2005. Intervention(s): Reproductive outcome was compared based on the application (or not) of OCP pretreatment: 944 women were included in the OCP group and 595 in the non-OCP group. The Student's t test was used for statistics. Main Outcome Measure(s): Pregnancy, biochemical pregnancy, ectopic pregnancy, early clinical pregnancy loss, early pregnancy loss, and ongoing pregnancy rates. Result(s): No significant differences were observed in any of the outcome parameters. Early pregnancy loss rates were similar: 23% in the OCP pretreatment group versus 19.2% in the non-OCP pretreatment group. However, longer periods of ovarian stimulation and higher doses of gonadotropins needed to be employed in the OCP group. Conclusion(s): There is not sufficient evidence to confirm OCP pretreatment as a risk factor for miscarriage in patients stimulated with GnRH antagonist protocols.
引用
收藏
页码:1098 / 1101
页数:4
相关论文
共 50 条
  • [1] Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis
    Griesinger, Georg
    Kolibianakis, Efstratios Michaelis
    Venetis, Christos
    Diedrich, Klaus
    Tarlatzis, Basil
    [J]. FERTILITY AND STERILITY, 2010, 94 (06) : 2382 - 2384
  • [2] A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis
    Fedele, Luigi
    Bianchi, Stefano
    Montefusco, Sarah
    Frontino, Giada
    Carmignani, Luca
    [J]. FERTILITY AND STERILITY, 2008, 90 (01) : 183 - 184
  • [3] Effects of the gonadotropin-releasing hormone antagonist cetrorelix in the early postimplantation period on rat pregnancy
    Tug, Niyazi
    Uslu, Unal
    Cumbul, Alev
    Eyuboglu, Signem
    Cam, Cetin
    Karateke, Ates
    Yilmaz, Bayram
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 155 (02) : 166 - 170
  • [4] Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates
    Biljan, MM
    Mahutte, NG
    Dean, N
    Hemmings, R
    Bissonnette, F
    Tan, SL
    [J]. FERTILITY AND STERILITY, 1998, 70 (06) : 1063 - 1069
  • [5] Gonadotropin-releasing hormone-stimulated gonadotropin levels in women with premenstrual dysphoria
    Smith, MJ
    Schmidt, PJ
    Su, TP
    Rubinow, DR
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2004, 19 (06) : 335 - 343
  • [6] Relugolix, an oral gonadotropin-releasing hormone antagonist for the treatment of prostate cancer
    George, Daniel J.
    Dearnaley, David P.
    [J]. FUTURE ONCOLOGY, 2021, 17 (33) : 4431 - 4446
  • [7] Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels
    Chen, Liang-Hsuan
    Chin, Tzu-Hsuan
    Huang, Shang-Yu
    Yu, Hsing-Tse
    Chang, Chia-Lin
    Huang, Hong-Yuan
    Wang, Hsin-Shih
    Soong, Yung-Kuei
    Wu, Hsien-Ming
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2021, 60 (04): : 739 - 744
  • [8] Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix
    Struthers, R. Scott
    Nicholls, Andrew J.
    Grundy, John
    Chen, Takung
    Jimenez, Roland
    Yen, Samuel S. C.
    Bozigian, Haig P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02): : 545 - 551
  • [9] Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
    Mohamad Shebley
    Akshanth R. Polepally
    Ahmed Nader
    Juki W. Ng
    Insa Winzenborg
    Cheri E. Klein
    Peter Noertersheuser
    Megan A. Gibbs
    Nael M. Mostafa
    [J]. Clinical Pharmacokinetics, 2020, 59 : 297 - 309
  • [10] Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
    Shebley, Mohamad
    Polepally, Akshanth R.
    Nader, Ahmed
    Ng, Juki W.
    Winzenborg, Insa
    Klein, Cheri E.
    Noertersheuser, Peter
    Gibbs, Megan A.
    Mostafa, Nael M.
    [J]. CLINICAL PHARMACOKINETICS, 2020, 59 (03) : 297 - 309